Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.. HelmGuard Raises $7.3M Seed Round to Replace Compliance Paperwork with AI Agents that Verify Risk Directly. HelmGuard, the agentic governance, risk and compliance (GRC) and security platform co-founded by a former Palantir executive, today announced a $7.3M seed round, co-led by Infinity Ventures and Frontline, with participation from FinTech Collective, Stage 2 Capital, and Entrepreneurs First.
The company’s AI agents collect and assess risk signals directly from source systems, cutting assessment cycles from weeks to hours.. The funding will support continued expansion in the U.S. market, including a New York and San Francisco presence, hiring across engineering and go-to-market, and accelerated development of an agent assurance layer that evaluates AI agent behavior at runtime..
Firms in regulated sectors, such as financial services, insurance, healthcare, and industrials, spend billions of dollars annually compiling and reviewing documentation to assess and manage their security and compliance. The legacy platforms they use to assist them are document- and process-oriented, focused more on questionnaires, templated reports and checklist completion than operational decision-making.
While other platforms now use AI to generate and process paperwork faster, they still can’t help users understand the relationship between a risk and a mitigating control, whether a vendor is safe to rely upon, or if an agent is behaving as it should.. HelmGuard takes a different approach by unifying fragmented risk, security, and compliance data into a single interconnected network drawing on unstructured data and documentation as well as direct integration with source systems.
The platform then uses specialized AI agents to automate workflows such as third-party risk management, agent assurance and control gap assessments and synthesize the results into a single, firm-wide view. Transparent citations, reasoning traces and human-in-the-loop mechanisms provide a defensible basis on which teams can operate and report to internal and external stakeholders, auditors and regulators..
John Daley, Co-Founder and CEO at HelmGuard, who spent eight years as an executive at Palantir, said, “Most compliance platforms were built to document a process, not to reach a conclusion. Now they’re using AI to produce those documents faster, which doesn’t help anyone decide anything.
Our agents go to the source to collect and assess risk signals directly, abstracting away the manual data collection and assessment work that burns thousands of hours annually. This funding lets us…. Full release here, originally announced September 9th, 2026..
Forus Raises $150M at a $3B Valuation as Its AI Network Becomes How Medicine Reaches Patients. Forus Triples its Valuation Within Months of its Series B, in an Insider-Led Round Backed by Every Existing Investor, as it Scales Toward Putting its AI Platform in Every Doctor’s Office in the Country.
Forus, the AI network accelerating medicine, today announced $150 million in Series C financing at a $3 billion valuation, tripling its valuation just months after announcing its Series B and bringing total funding to more than $300 million. The round was led by Bain Capital Ventures, an investor in Forus since its seed round.
Every existing institutional investor is reinvesting, including Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Avra, Human Capital, Neo, Vast Ventures, and SV Angel.. Forus is the AI network for medicine: the platform connecting doctors, pharmacies, payers, and biopharma to bring new science to the patients who need it..
Forus is national and supporting millions of people, now used by providers across all 50 states to treat patients in 85% of U.S. residential ZIP codes. More than a third of providers in the country have adopted the platform in the first launched specialty, with double-digit percentages of providers nationwide across multiple other specialties following suit.
Forus will use the funding to expand to all specialties and care settings, extend what its AI agents can do across the entire path to treatment, and accelerate investment in its team.. “We are putting the Forus platform in every doctor’s office in the country, so every disease is treated with the best medicine science can offer,” said Sahir Jaggi, Founder and CEO at Forus….
Full release here, originally announced September 8th, 2026.. . Get Fresh Healthcare & IT Stories Delivered Daily. Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter..
We respect your privacy and will never sell or give out your contact information
